Novel erythropoietin-loaded nanoparticles with prolonged in vivo response

References

• Barenholz Y. Liposome application: Problems and prospects. Curr Opin Colloid Interface Sci 2000; 6: 66–77
   Web of Science ®Google Scholar
• Caminad AM, Laurent R, Majora JP. Characterization of dendrimers. Adv Drug Delivery Rev 2005; 57: 2130–46
   PubMed Web of Science ®Google Scholar
• Cherian AK, Rana AC, Jain SK. Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin. Drug Dev Ind Pharm 2000; 4: 459–63
   Google Scholar
• Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14: 1310–16
   PubMed Web of Science ®Google Scholar
• pharm. CHO-A, Research for EPO production [Online]. Available at: http://www.choa.co.kr/eng/research/epo01.asp. Accessed 01 April 2011
   Google Scholar
• Couvreur P. Polyalkylcyanoacrylates as colloidal drug carrier. Crit Rev Ther Drug Carrier Syst 1988; 5: 1–20
   PubMed Web of Science ®Google Scholar
• Dahier F, Lecouturier N, Vroman B, Jerome C, Brynaert JM, Feron O, Preat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Controlled Release 2009; 133: 11–17
   PubMed Web of Science ®Google Scholar
• Deyl Z. Electrophoresis: A survey of techniques and applications. Part A: Techniques. Elesevier Scientific, New York, Amsterdam 1979
   Google Scholar
• Dunn M, Crisp S. Detection of proteins in polyacrylamide gels using an ultrasensitive silver staining technique. Basic protein and peptides protocols, J Walker. Humana Press, Totowa, NJ 1994; 113–18
   Google Scholar
• Elliott S, Pham E, Macdougall IC. Erythropoietins: A common mechanism of action. Exp Hematol 2008; 36: 1573–84
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia Commission. 2005. European Pharmacopoeia (Ph. Eur. 5.3). 5th ed. Strasbourg, France: European Pharmacopoeia Commission, pp. 3494–8.
   Google Scholar
• Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Controlled Release 2008; 130: 259–65
   PubMed Web of Science ®Google Scholar
• Jain SK, Chaurasiya Gupta AY. Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumor targeting. J Microencapsulation 2008; 25: 289–97
   PubMed Web of Science ®Google Scholar
• Jain A, Jain SK. In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. Eur J Pharm Sci 2008; 35: 404–16
   PubMed Web of Science ®Google Scholar
• Jones MC, Leroux JC. Polymeric micelles – a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999; 48: 101–11
   PubMed Web of Science ®Google Scholar
• Kamei S, Kamijo A, Saikawa A, Igari Y, Ogawa Y. Influence of low molecular weight fraction of polymer on entrapment and initial release of leuprorelin. Proc Int Symp Control Release Bioact Mater 1996; 23: 347–8
   Google Scholar
• Koury ST, Bondurant MC, Koury MJ. Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization. Blood 1988; 71: 524–7
   PubMed Web of Science ®Google Scholar
• Koury ST, Bondurant MC, Koury MJ. Localization of cells producing erythropoietin in murine liver by in situ hybridization. Blood 1991; 77: 2497–503
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: Preparation and characterization. Int J Pharm 2007; 16: 153–62
   Google Scholar
• Morlock M, Kissel T, Li XY, Koll H, Winter G. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: Protein stabilization and in-vitro release properties. J Controlled Release 1998; 56: 105–15
   PubMed Web of Science ®Google Scholar
• Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin using biodegradable poly(D, L-lactide-co-glycolide): Protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 1997; 43: 29–36
   Web of Science ®Google Scholar
• Nguyen KT, Shukla KP, Moctezuma M, Braden ARC, Zhou J, Hu Z, Tang L. Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells. J Biomed Mater Res A 2008; 88: 1020–30
   Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Delivery Rev 2003; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007; 2: 751–60
   PubMed Web of Science ®Google Scholar
• Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticle. Nanomed Nanotechnol Biol Med 2006; 2: 8–21
   PubMed Web of Science ®Google Scholar
• Sabbatini P. Strategies for optimizing hemoglobin response in cancer patients: Focus on new epoetin alfa dosing regimens. Eur J Cancer Suppl 2004; 2: 36–40
   Google Scholar
• Sifakis S, Angelakis E, Vardaki E, Koumantaki Y, Matalliotakis I, Koumantakis E. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. Gynecol Obstet Invest 2001; 51: 150–6
   PubMed Web of Science ®Google Scholar
• Singh S, Muthu MS. Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine 2007; 2: 233–40
   PubMed Web of Science ®Google Scholar
• Sipsas NV, Kokori SI, Ioannidis JP, Kyriaki D, Tzioufas AG, Kordossis T. Circulating autoantibodies to erythropoietin are associated with human immunodeficiency virus type 1-realted anemia. J Infect Des 1999; 180: 2044–7
   Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Subodh S, 2000. Biodegradable microparticles for the sustained delivery of therapeutic drugs, Patent no. 6020004, USA
   Google Scholar
• Venkatesan N, Yoshimitsu J, Lto Y, Shibata N. Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials 2005; 26: 7154–63
   PubMed Web of Science ®Google Scholar
• William B, James A, Pratt D. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease. Clin Ther 2007; 29: 1368–80
   PubMed Web of Science ®Google Scholar
• Williams D. The relationship between biomaterials and nanotechnology. Biomaterials 2008; 29(12): 1737–8
   Web of Science ®Google Scholar
• Yassin AEB, Anwer MK, Mowafy HA, El-Bagory IM, Bayomi MA, Alsarra IA. Optimization of 5-flurouracil solid-lipid nanoparticles: A preliminary study to treat colon cancer. Int J Med Sci 2010; 6: 398–408
   Google Scholar
• Zale SE, Burke PA, Bernstein H, Brickner A, 1998. Composition for sustained release of non-aggregated erythropoietin, Patent no. 5716644, USA
   Google Scholar